Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
106.49
-0.80 (-0.75%)
At close: Nov 4, 2024, 4:00 PM
113.95
+7.46 (7.01%)
Pre-market: Nov 5, 2024, 8:27 AM EST
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $13.17 billion as of November 5, 2024. Its market cap has increased by 201.85% in one year.
Market Cap
13.17B
Enterprise Value
11.75B
1-Year Change
201.85%
Ranking
Category
Stock Price
$106.49
Market Cap Chart
Since June 12, 2020, Vaxcyte's market cap has increased from $1.22B to $13.17B, an increase of 977.33%. That is a compound annual growth rate of 71.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 11.97B | 100.39% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.57% |
| Dec 31, 2021 | 1.26B | -7.23% |
| Dec 31, 2020 | 1.35B | 10.71% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incyte | 14.67B |
| Genmab | 14.31B |
| Summit Therapeutics | 14.00B |
| Viatris | 13.87B |
| Universal Health Services | 13.69B |
| Exact Sciences | 12.90B |
| BioMarin Pharmaceutical | 12.69B |
| Solventum | 12.51B |